Table 1:
Age at baseline | |||
---|---|---|---|
15-19 years | 20-24 years | Overall | |
N = 176,019 | N = 606,435 | N = 782,454 | |
Sex | |||
Female | 160,937 (91.4) | 537,129 (88.6) | 698,066 (89.2) |
Male | 15,082 (8.6) | 69,306 (11.4) | 84,388 (10.8) |
Calendar period | |||
2004 – 2007 | 31,916 (18.1) | 136,298 (22.5) | 168,214 (21.5) |
2008 – 2011 | 90,375 (51.3) | 307,037 (50.6) | 397,412 (50.8) |
2012 – 2014 | 53,728 (30.5) | 163,100 (26.9) | 216,828 (27.7) |
Median baseline CD4 cell count [IQR] [cells/μL] | 386 [253-548] | 349 [216-511] | 357 [224-520] |
Baseline CD4 cell count [cells/μL] | |||
<200 | 26,392 (15.0) | 121,553 (20.0) | 147,945 (18.9) |
200-499 | 82,462 (46.8) | 282,455 (46.6) | 364,917 (46.6) |
≥500 | 49,690 (28.2) | 144,968 (23.9) | 194,658 (24.9) |
Missing | 17,475 (9.9) | 57,459 (9.5) | 74,934 (9.6) |
Baseline HIV RNA viral load [copies/ml] | |||
<1,000 | 8,579 (4.9) | 32,453 (5.4) | 41,032 (5.2) |
≥1,000 | 10,496 (6.0) | 34,333 (5.7) | 44,829 (5.7) |
Missing | 156,944 (89.2) | 539,649 (89.0) | 696,593 (89.0) |
Results are presented as counts and percentages if not otherwise stated.